News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Drug Giant Bristol-Myers Squibb (BMY) Ties it Up With Another Bay Area Firm in Cancer Immunotherapy Quest     9/27/2016
Cancer Immunotherapy Startup Fortis Therapeutics Launches With $18 Million Series A     9/27/2016
Investors Beware: Thin CAR-T Data Could Make or Break Juno (JUNO) and Kite Pharma (KITE)     9/23/2016
Genentech (RHHBY) Gambles $310 Million+ on German Biotech BioNTech's mRNA Cancer Vaccine Tech     9/23/2016
Clovis Oncology (CLVS) Stock Jumps as FDA Skips Review Panel for New Cancer Drug     9/12/2016
Juno (JUNO) Surges as Small Cancer Study is Hailed a Success, Shows Promise for Other Drugs     9/9/2016
Cancer Drug Developed by Eliza Hall Institute, AbbVie (ABBV) and Genentech (RHHBY) “Melts Away Cancer”     9/7/2016
Rigontec GmbH Raises Additional €15 Million In Extended Series A To Advance Novel RIG-I Targeted Immuno-Oncology Therapeutics     9/6/2016
3 Biotechs Expecting to Release Clinical Trial Data Soon     9/1/2016
OncoGenex (OGXI) Hires Advisor, Seeks Strategic Alternatives After Cancer Drug Custirsen Study Fails     8/16/2016
CASI Pharma (CASI) Met Endpoint in Phase II ENMD-2076 in Fibrolamellar Carcinoma     8/16/2016
ProNAi Therapeutics Shuts Down Research Site for Failed Cancer Candidate PNT2258     8/15/2016
San Diego's MEI Pharma (MEIP) Bags Cancer Deal Worth $464 Million With Helsinn     8/9/2016
Amgen (AMGN) Forges Pre-clinical R&D Pact Worth $540 Million With Advaxis (ADXS)     8/4/2016
After Bagging $51 Million in Early 2016, Bay Area's Adicet Bio Inks a Five-Year R&D Deal with Regeneron (REGN)     8/2/2016

News from Around the Web
Researcher In Quest To Find A Cure For His Own Incurable Cancer     9/26/2016
Top Scientists Cautious About Fighting Cancer With Immunotherapy     9/26/2016
15 Cancer Causing Foods You Probably Eat Every Day     9/22/2016
Massive Sinkhole In Florida Is Leaking Radioactive Water Into The Ground     9/20/2016
Cancer-Risk Genetic Testing Reports Can Vary From Lab To Lab     9/20/2016
Despite Trial Deaths, Juno (JUNO) Could Still Be the CAR-T Leader     9/13/2016
What's Behind FDA's Warning Against Ovarian Cancer Screening Tests?     9/13/2016
Cancer Cures Could Already Exist In Big Data     9/8/2016
The Good And Bad Of Immunotherapy     9/7/2016
Vitamin A Compound Retinoic Acid May Help Fight Colorectal Cancer Risk, Stanford University Study     9/2/2016
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Most Experts Who Develop Cancer Treatment Guidelines Have Ties To Industry     8/26/2016
Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, UCSF Study Says     8/25/2016
Pfizer (PFE)'s $14 Billion Buy Signals That Cancer Drug Prices Will Remain High     8/23/2016
CAR-T: An Experimental Cancer Therapy That Holds Great Promise But At A Great Cost     8/23/2016

Press Releases
ProNAi Therapeutics Strikes a $328.5 Million Cancer Deal With CRT Pioneer Fund     9/27/2016
Infinity Pharma (INFI) Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference     9/27/2016
Clinical Data Support Mechanism Of Action And Patient Selection Biomarker For Imprime PGG, Biothera's Phase II Cancer Immunotherapy     9/27/2016
New Study Opens Window For OncBioMune Cancer Vaccine In Early And Advanced Prostate Cancer Patients     9/27/2016
Ipsen (IPN.PA) Announces Data Presentations Of Cabozantinib (Cabometyx), Lanreotide (Somatuline® Autogel®) And Telotristat Ethyl* At The European Society For Medical Oncology (ESMO) 2016 Congress     9/27/2016
Oxford Gene Technology Ltd. Simplifies Detection Of Important Cancer Gene Variants     9/27/2016
BerGenBio AS: New BGB324 Study Points To Novel Mechanism To Enhance Immunotherapy Efficacy     9/26/2016
AnaptysBio Announces Checkpoint Receptor Agonist Antibody Portfolio     9/26/2016
MD Anderson Cancer Center And Adaptimmune (ADAP) Form Strategic Alliance To Advance Development Of Immunotherapies Targeting Multiple Cancers     9/26/2016
Salk Institute for Biological Studies Release: Targeting Fat To Treat Cancer     9/23/2016
Gustave Roussy Release: The Prospective MOSCATO 01 Trial Demonstrates That Molecular "Portraits" Improve Outcome Of Patients With Metastatic Cancer     9/23/2016
German Immuno-Oncology Upstart iOmx Therapeutics Bags EUR 40 Million Series A     9/22/2016
NW Bio (NWBO) Presents Updated Data From DCVax-Direct Phase I Trial At 5th Annual SMi Cancer Vaccines Conference In London     9/22/2016
First Patient Enrolled In Toca 6, Tocagen's Trial For Metastatic Cancers Evaluating Intravenously Delivered Toca 511 Virus     9/22/2016
Agilent (A) Launches New Panel For Fast FISH Testing On Dako Omnis In Lung Cancer     9/22/2016